You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HRTX Exercise Disclosure
Forbes William P · SEC Form 4 · Filed Aug 3, 2026
Exercise
Reported value range
Not reported
Forbes William P EVP, Chief Development Officer
HRTX
Heron Therapeutics
HRTX
Transaction date
Jul 31, 2026
Public filing date
Aug 3, 2026
Filing lag
Filed 3 days later
HRTX daily price context
Close on/before transaction
$0.5
Jul 31, 2026
First close after public filing
$0.51
Aug 3, 2026
30-day return after filing
-38.82%
Through Sep 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 11,694 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001193125-26-329804
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$3.34K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Heron Therapeutics, Inc. /De/ HRTX | Exercise | Jul 31, 2026 | $0 |
| Heron Therapeutics, Inc. /De/ HRTX | Disposition | Jul 31, 2026 | $1.66K |
| Heron Therapeutics, Inc. /De/ HRTX Current | Exercise | Jul 31, 2026 | Not reported |
| Heron Therapeutics, Inc. /De/ HRTX | Disposition | Jul 30, 2026 | $1.67K |
| Heron Therapeutics, Inc. /De/ HRTX | Exercise | Jul 30, 2026 | Not reported |
| Heron Therapeutics, Inc. /De/ HRTX | Exercise | Jul 30, 2026 | $0 |